Cyclization of the Urokinase Receptor-Derived Ser-Arg-Ser-Arg-Tyr Peptide Generates a Potent Inhibitor of Trans-Endothelial Migration of Monocytes
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cyclization of the Urokinase Receptor-Derived Ser-Arg-Ser-Arg-Tyr Peptide Generates a Potent Inhibitor of Trans-Endothelial Migration of Monocytes
Authors
Keywords
-
Journal
PLoS One
Volume 10, Issue 5, Pages e0126172
Publisher
Public Library of Science (PLoS)
Online
2015-05-05
DOI
10.1371/journal.pone.0126172
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Urokinase receptor promotes ovarian cancer cell dissemination through its 84-95 sequence
- (2015) Katia Bifulco et al. Oncotarget
- UPARANT: A Urokinase Receptor-Derived Peptide Inhibitor of VEGF-Driven Angiogenesis with Enhanced Stability and In Vitro and In Vivo Potency
- (2014) M. V. Carriero et al. MOLECULAR CANCER THERAPEUTICS
- Role of formyl peptide receptor 2 on the serum amyloid A-induced macrophage foam cell formation
- (2013) Ha Young Lee et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- suPAR: The Molecular Crystal Ball
- (2013) Maria Thunø et al. DISEASE MARKERS
- Targeting cells in motion: Migrating toward improved therapies
- (2013) Jason W. Griffith et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Monocyte ADAM17 Promotes Diapedesis during Transendothelial Migration: Identification of Steps and Substrates Targeted by Metalloproteinases
- (2013) Y. Tsubota et al. JOURNAL OF IMMUNOLOGY
- A Urokinase Receptor-Derived Peptide Inhibiting VEGF-Dependent Directional Migration and Vascular Sprouting
- (2013) K. Bifulco et al. MOLECULAR CANCER THERAPEUTICS
- Truncated and Helix-Constrained Peptides with High Affinity and Specificity for the cFos Coiled-Coil of AP-1
- (2013) Tara Rao et al. PLoS One
- Ectoenzymes controlling leukocyte traffic
- (2012) Marko Salmi et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- G protein-coupled receptor FPR1 as a pharmacologic target in inflammation and human glioblastoma
- (2012) Mingyong Liu et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Crystal Structure of the Urokinase Receptor in a Ligand-Free Form
- (2012) Xiang Xu et al. JOURNAL OF MOLECULAR BIOLOGY
- Single Amino Acid Substitutions in the Chemotactic Sequence of Urokinase Receptor Modulate Cell Migration and Invasion
- (2012) Katia Bifulco et al. PLoS One
- The Urokinase-type Plasminogen Activator and the Generation of Inhibitors of Urokinase Activity and Signaling
- (2011) Maria Vincenza Carriero et al. CURRENT PHARMACEUTICAL DESIGN
- Conformational Regulation of Urokinase Receptor Function
- (2011) Henrik Gårdsvoll et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Plasma level of soluble urokinase-type plasminogen activator receptor as a predictor of disease severity and case fatality in patients with bacteraemia: a prospective cohort study
- (2011) R. Huttunen et al. JOURNAL OF INTERNAL MEDICINE
- The cross-talk between the urokinase receptor and fMLP receptors regulates the activity of the CXCR4 chemokine receptor
- (2010) Nunzia Montuori et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- The soluble form of urokinase receptor promotes angiogenesis through its Ser88-Arg-Ser-Arg-Tyr92 chemotactic sequence
- (2010) K. BIFULCO et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Structure-based design of an urokinase-type plasminogen activator receptor-derived peptide inhibiting cell migration and lung metastasis
- (2009) M. V. Carriero et al. MOLECULAR CANCER THERAPEUTICS
- An urokinase receptor antagonist that inhibits cell migration by blocking the formyl peptide receptor
- (2008) Katia Bifulco et al. FEBS LETTERS
- Moving targets: cell migration inhibitors as new anti-inflammatory therapies
- (2008) Charles R Mackay NATURE IMMUNOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now